In a nutshell This study compared different chemotherapy regimens and rituximab (Rituxan) for the initial treatment of advanced follicular lymphoma. This study concluded that the combinations R-CHOP and R-FM were more effective than R-CVP. R-CHOP was associated with fewer severe side effects than R-FM. Some background Follicular lymphoma (FL) is...
Read More
In a nutshell This study explored whether radiation therapy was necessary in patients with early-stage Hodgkin lymphoma. The study concluded that disease progression occurred more often in patients who did not undergo radiation. Some background The standard treatment option for early stage Hodgkin lymphoma is chemotherapy followed by radiation....
Read MoreIn a nutshell This trial examined which children with Hodgkin lymphoma benefit from radiation therapy after chemotherapy. The authors concluded that patients with a combination of bulky disease (tumors larger than 6 cm) and anemia (low levels of red blood cells) benefited most. Some background Hodgkin lymphoma is a cancer of the lymph...
Read More
In a nutshell The current study examined the use of involved node radiation therapy with different delivery techniques in patients with early-stage Hodgkin lymphoma. The study suggests that radiation to a smaller area is safe and effective in these patients. Some background The main treatment options for Hodgkin lymphoma are chemotherapy combined...
Read More
In a nutshell This study reviewed the treatment options for early-stage Hodgkin lymphoma. Some background Early-stage Hodgkin lymphoma refers to stages I and II. Early-stage can be further divided into favorable or unfavorable. Patients with unfavorable disease may present with certain risk factors. These include large chest tumors, inflammation...
Read More
In a nutshell This study examined whether the number of chemotherapy agents in the combination ABVD could be reduced when treating Hodgkin lymphoma. The authors concluded that to be effective all four chemotherapies need to be included. Some background More than 80% of patients with early-stage, favorable Hodgkin lymphoma experience long-term...
Read More
